Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Management of Concurrent Malignant Phyllodes Tumor and Invasive Breast Carcinoma.

Autor: Chen JJ; Department of Radiation Oncology, University of California, San Francisco, San Francisco, California., Zhu I; Department of Radiation Oncology, University of California, San Francisco, San Francisco, California., Patel A; Memorial Sloan Kettering Cancer Center, New York, New York., Krings G; Department of Pathology, University of California, San Francisco, San Francisco, California., Chen YY; Department of Pathology, University of California, San Francisco, San Francisco, California., Yuen F; Department of Radiation Oncology, University of California, San Francisco, San Francisco, California., Mukhtar RA; Division of Surgical Oncology, University of California, San Francisco, San Francisco, California., Melisko M; Department of Medicine - Hematology/Oncology, University of California, San Francisco, San Francisco, California., Singer L; Department of Radiation Oncology, University of California, San Francisco, San Francisco, California., Park CC; Department of Radiation Oncology, University of California, San Francisco, San Francisco, California., Prionas ND; Department of Radiation Oncology, University of California, San Francisco, San Francisco, California.

Publikováno v: Advances in radiation oncology [Adv Radiat Oncol] 2024 Jan 26; Vol. 9 (5), pp. 101448. Date of Electronic Publication: 2024 Jan 26 (Print Publication: 2024).

Early-stage Breast Cancer: Tailored External Beam Fractionation Approaches for Treatment of the Whole or Partial Breast.

Autor: Prionas ND; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA., Stephens SJ; Department of Radiation Oncology, Duke University, Durham, NC., Blitzblau RC; Department of Radiation Oncology, Duke University, Durham, NC.. Electronic address: rachel.blitzblau@duke.edu.

Publikováno v: Seminars in radiation oncology [Semin Radiat Oncol] 2022 Jul; Vol. 32 (3), pp. 245-253.

Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patients.

Autor: Levin-Epstein R; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, United States., Cook RR; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, United States., Wong JK; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, United States., Stock RG; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, United States., Jeffrey Demanes D; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, United States; California Endocurietherapy Cancer Center, Oakland, United States., Collins SP; Department of Radiation Medicine, Georgetown University Hospital, Washington, United States., Aghdam N; Department of Radiation Medicine, Georgetown University Hospital, Washington, United States., Suy S; Department of Radiation Medicine, Georgetown University Hospital, Washington, United States., Mantz C; 21(st) Century Oncology, Inc., Fort Myers, United States., Katz AJ; FROS Radiation Oncology and Cyberknife Center, Flushing, United States., Nickols NG; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, United States; Department of Radiation Oncology, West Los Angeles Veterans Health Administration, Los Angeles, United States., Miszczyk L; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Gliwice Branch, Gliwice, Poland., Napieralska A; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Gliwice Branch, Gliwice, Poland., Namysl-Kaletka A; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Gliwice Branch, Gliwice, Poland., Prionas ND; Department of Radiation Oncology, Stanford University Medical Center, Stanford, United States., Bagshaw H; Department of Radiation Oncology, Stanford University Medical Center, Stanford, United States., Buyyounouski MK; Department of Radiation Oncology, Stanford University Medical Center, Stanford, United States., Cao M; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, United States., Mahal BA; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, United States., Shabsovich D; David Geffen School of Medicine, University of California, Los Angeles, United States., Dang A; Department of Radiation Oncology, Tulane Medical Center, New Orleans, United States., Yuan Y; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, United States., Rettig MB; Department of Medical Oncology, University of California Los Angeles, Los Angeles, United States; Department of Medical Oncology, West Los Angeles Veterans Health Administration, Los Angeles, United States., Chang AJ; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, United States., Jackson WC; Department of Radiation Oncology, University of Michigan, Ann Arbor, United States., Spratt DE; Department of Radiation Oncology, University of Michigan, Ann Arbor, United States., Lehrer EJ; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, United States., Zaorsky NG; Department of Radiation Oncology, Penn State Cancer Institute, Hershey, United States., Kupelian PA; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, United States., Steinberg ML; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, United States., Horwitz EM; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, United States., Jiang NY; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, United States., Kishan AU; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, United States. Electronic address: aukishan@mednet.ucla.edu.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2020 Oct; Vol. 151, pp. 26-32. Date of Electronic Publication: 2020 Jul 11.

Predicting Survival for Patients With Metastatic Disease.

Autor: Benson KRK; Radiation Oncology Department, Stanford Cancer Institute, Stanford, California., Aggarwal S; Radiation Oncology Department, Stanford Cancer Institute, Stanford, California., Carter JN; Radiation Oncology Department, Stanford Cancer Institute, Stanford, California., von Eyben R; Radiation Oncology Department, Stanford Cancer Institute, Stanford, California., Pradhan P; Radiation Oncology Department, Stanford Cancer Institute, Stanford, California., Prionas ND; Radiation Oncology Department, Stanford Cancer Institute, Stanford, California., Bui JL; Radiation Oncology Department, Stanford Cancer Institute, Stanford, California., Soltys SG; Radiation Oncology Department, Stanford Cancer Institute, Stanford, California., Hancock S; Radiation Oncology Department, Stanford Cancer Institute, Stanford, California., Gensheimer MF; Radiation Oncology Department, Stanford Cancer Institute, Stanford, California., Koong AC; Radiation Oncology Department, MD Anderson Cancer Center, Houston, Texas., Chang DT; Radiation Oncology Department, Stanford Cancer Institute, Stanford, California. Electronic address: dtchang@stanford.edu.

Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2020 Jan 01; Vol. 106 (1), pp. 52-60. Date of Electronic Publication: 2019 Nov 01.